Outlier mining in high throughput screening experiments

Journal of Biomolecular Screening

Volumn 7, Issue 4, 2002, Pages 341-351

  Engels, Michael F M ^a   Wouters, Luc ^a,b   Verbeeck, Rudi ^a   Vanhoof, Greet ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; NSC 640365; NSC 657151; NSC 657152; NSC 659016; NSC 659018; NSC 659019; NSC 659020; NSC 685576; NSC 687374; NSC 705957; UNCLASSIFIED DRUG;

ACCURACY; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; CALCULATION; DRUG SCREENING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS; ALGORITHM; BIOLOGY; COMPUTER SIMULATION; FACTUAL DATABASE; INFORMATION RETRIEVAL; METHODOLOGY; PROSPECTIVE STUDY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL ANALYSIS; STATISTICS;

ALGORITHMS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; DRUG EVALUATION, PRECLINICAL; INFORMATION STORAGE AND RETRIEVAL; PROSPECTIVE STUDIES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036670599     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1089/108705702320351196     Document Type: Article

References (37)

1. Development of an automated high-throughput screening system: A case history
2. Allegro: Moving the bar upwards
3. The evolution of miniaturized well plates
4. What is the future of high throughput screening?
5. Molecular diversity in drug design: Application to high-speed synthesis and high-throughput screening
6. Drug screening - Beyond the bottleneck
7. Confirmation of primary active substances from high throughput screening of chemical and biological populations: A statistical approach and practical considerations
8. Binary quantitative structure-activity relationship (QSAR) analysis of estrogen receptor ligands
9. QuaSAR-binary: A new method for the analysis of high throughput screening data
10. Some thoughts on assay validation and quality control in high-throughput screening
11. Statistical considerations in high throughput screening
12. Multivariate outlier detection
13. Location of several outliers in multiple-regression data using elemental sets
14. Robust orthogonal regression for the outlier detection when comparing two series of measurement results
15. Fast very robust methods for the detection of multiple outliers
16. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?
17. A scoring scheme discriminating between drugs and nondrugs
18. Choosing between logistic regression and discriminant analysis
19. Quantitative structure-activity studies of pyrethroids
20. Empirical modeling of an in-vitro activity of polychlorinated biphenyl congeners and mixtures
21. Generalized linear models
22. The information content of 2D and 3D structural descriptors relevant to ligand-receptor binding
23. Use of structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection
24. New soluble-formazan assay for HIV-1 cytopathic effects: Application to high-flux screening of synthetic and natural products for AIDS-antiviral activity
25. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
26. A simple statistical parameter for use in evaluation and validation of high throughput screening assays
27. Diversity analysis in high throughput screening
28. Approaches for mining high-throughput screening data sets
29. CerBeruS: A system supporting the sequential screening process
30. Pharmacophore fingerprinting. 1. Application to QSAR and focused library design
31. New 4-point pharmacophore method for molecular similarity and diversity applications: Overview of the method and applications, including a novel approach to the design of combinatorial libraries
32. Implementation of an outlier detection method for high throughput screening in drug discovery